Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial

Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial

Background: MLC601 is a possible modulator of amyloid precursor protein processing, and in a clinical trial study MLC601 showed some effectiveness in cognitive function in Alzheimer's disease (AD) patients. We aimed to evaluate the effectiveness and safety of MLC601 in the treatment of mild to...

Full description

Bibliographic Details
Main Authors: Hossein Pakdaman, Ali Amini Harandi, Hamidreza Hatamian, Mojgan Tabatabae, Hosein Delavar Kasmaei, Amirhossein Ghassemi, Koroush Gharagozli, Farzad Ashrafi, Pardis Emami Naeini, Mehrnaz Tavakolian, Darush Shahin
Format: Article
Language:English
Published: Karger Publishers 2015-03-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Cholinesterase inhibitor
Alzheimerߣs disease
Donepezil
Rivastigmine
Galantamine
MLC601
Safety
Efficacy
Online Access:http://www.karger.com/Article/FullText/375295

Internet

http://www.karger.com/Article/FullText/375295

Similar Items